{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:56:08Z","timestamp":1786636568847,"version":"build-2736575974"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Afr Med"],"published-print":{"date-parts":[[2012]]},"DOI":"10.4103\/1596-3519.91011","type":"journal-article","created":{"date-parts":[[2011,12,20]],"date-time":"2011-12-20T02:40:42Z","timestamp":1324348842000},"page":"21","source":"Crossref","is-referenced-by-count":8,"title":["Electrocardiographic abnormalities among dialysis na\u00efve chronic kidney disease patients in Ilorin Nigeria"],"prefix":"10.4103","volume":"11","author":[{"given":"AM","family":"Makusidi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Chijioke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PM","family":"Kolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1596-3519.91011-1","first-page":"156","volume-title":"Echocardiograph assessment of left ventricular function in patients with chronic uraemia.Clin","author":"Cohen","year":"1979","journal-title":"Nephrol"},{"key":"key-10.4103\/1596-3519.91011-2","first-page":"743","volume-title":"Two - dimensional echocardiography finding in patients on haemodialysis for more than six months","author":"Cohen","year":"1987","journal-title":"Am J Cardiol"},{"key":"key-10.4103\/1596-3519.91011-3","first-page":"72","volume-title":"Survival of patient undergoing renal replacement therapy in one centre with special emphasis on racial differences","author":"Blayer","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/1596-3519.91011-4","unstructured":"USRDS 2004. Annual Data Reports: Atlas of End-stage-Renal disease in the United state national institute of health, national institute of diabetes and digestive and kidney disease. Bethesda: MD,. 2004."},{"key":"key-10.4103\/1596-3519.91011-5","first-page":"S5","volume-title":"Controlling the epidemic of cardiovascular disease in chronic kidney disease: where do we start.?","author":"Levey","year":"1998","journal-title":"Am J Kid Dis"},{"key":"key-10.4103\/1596-3519.91011-6","first-page":"1121","volume-title":"Level of kidney function as a risk factor for cardiovascular outcomes in the elderly","author":"Majunath","year":"2003","journal-title":"Kidney Int"},{"key":"key-10.4103\/1596-3519.91011-7","first-page":"S24","volume-title":"Chronic kidney disease and cardiovascular disease in the medicare population","author":"Collins","year":"2003","journal-title":"Kidney Int Suppl"},{"key":"key-10.4103\/1596-3519.91011-8","first-page":"S16","volume-title":"Epidemiology of cardiovascular disease in chronic renal disease","author":"Foley","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/1596-3519.91011-9","first-page":"547","volume-title":"Uraemic cardiomyopathy - effect of haemodialysis on left ventricular function in end stage renal failure","author":"Hung","year":"1980","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1596-3519.91011-10","first-page":"1468","volume-title":"Protenuria and the risk of developing end stage disease","author":"Iseki","year":"2003","journal-title":"Kidney Int"},{"key":"key-10.4103\/1596-3519.91011-11","first-page":"1307","volume-title":"Chronic kidney disease as a risk factor for cardiovascular disease and all - cause mortality.A pooled analysis of community based studies","author":"Weiner","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/1596-3519.91011-12","first-page":"489","volume-title":"Chronic kidney disease and the risk cardiovascular disease, replacement therapy and death in the United states medicare population.1998-1999","author":"Robert","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/1596-3519.91011-13","first-page":"350","volume-title":"End stage renal disease in developing countries","author":"Kher","year":"2002","journal-title":"Kidney Int"},{"key":"key-10.4103\/1596-3519.91011-14","first-page":"834","volume-title":"Value to corrected QT interval dispersion in identifying patients initiating dialysis at increased risk of total and cardiovascular mortality","author":"Beaubien","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/1596-3519.91011-15","first-page":"1","volume-title":"Prevalence of electrocardiographic left ventricular hypertrophy among incident dialysis patients in Maiduguri Nigeria","author":"Nwankwo","year":"2007","journal-title":"Res J Medicine & Med Sci"},{"key":"key-10.4103\/1596-3519.91011-16","first-page":"1606","volume-title":"The clinical epidemiology of cardiac disease in chronic renal failure","author":"Perfrey","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/1596-3519.91011-17","first-page":"76","volume-title":"Clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification.Part 5 evaluation of laboratory measurement for clinical assessment of kidney disease","author":"NKF-KDOQI","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/1596-3519.91011-18","first-page":"2089","volume-title":"Definition and classification of chronic kidney disease: A position statement from kidney disease improving global outcomes (KDIGO)","author":"Levey","year":"2005","journal-title":"Kidney Int"},{"key":"key-10.4103\/1596-3519.91011-19","first-page":"24","volume-title":"End stage renal disease: Racial differences","author":"Chijioke","year":"2003","journal-title":"Orient J Med"},{"key":"key-10.4103\/1596-3519.91011-20","first-page":"1296","volume-title":"Chronic kidney disease and the risk of death, cardiovascular events and hospitalization","author":"McCulloch","year":"2004","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1596-3519.91011-21","first-page":"354","volume-title":"Is pulse pressure useful in predicting risk for coronary heart disease.The Framingham Heart Study?","author":"Franklin","year":"1999","journal-title":"Circulation"},{"key":"key-10.4103\/1596-3519.91011-22","first-page":"1252","volume-title":"Late referral for end stage renal disease: A region wide survey in the southwest of England","author":"Paul","year":"2002","journal-title":"Nephrol Dial Transpl"},{"key":"key-10.4103\/1596-3519.91011-23","first-page":"S170","volume-title":"Detrimental effect of late referral in patients with chronic renal failure: A case control study","author":"Jungers","year":"1993","journal-title":"Kidney Int"},{"key":"key-10.4103\/1596-3519.91011-24","unstructured":"Oyediran AB, Akinkugbe OO. Chronic renal failure in Nigeria. Trop. Geog. Med. J.1970;22:41-45"},{"key":"key-10.4103\/1596-3519.91011-25","first-page":"131","volume-title":"Diseases causing chronic renal failure in Nigerians: A prospective study of 100 cases","author":"Akinsola","year":"1989","journal-title":"Afr J Med Med Sci"},{"key":"key-10.4103\/1596-3519.91011-26","first-page":"56","volume-title":"The clinical and laboratory evaluation of patients with chronic renal failure in UCH Ibadan before their first dialysis","author":"Salako","year":"1995","journal-title":"Dokita"},{"key":"key-10.4103\/1596-3519.91011-27","first-page":"404","volume-title":"Survival analysis of dialysis patients in Okinawa Japan","author":"Iseki","year":"1993","journal-title":"Kidney Int"},{"key":"key-10.4103\/1596-3519.91011-28","doi-asserted-by":"crossref","unstructured":"Walker WG, Neaton JD, Cutler JA, Newwirth R, Cohen JD. Renal function change in hypertensive members of Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group. JAMA 1992;268:3085-91.","DOI":"10.1001\/jama.268.21.3085"},{"key":"key-10.4103\/1596-3519.91011-29","first-page":"1398","volume-title":"Cardiovascular disease in patients with CKD: Getting to the heart of the matter","author":"Adeera","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/1596-3519.91011-30","first-page":"163","volume-title":"Cardiovascular mortality in end stage renal disease","author":"Collins","year":"2003","journal-title":"Am J Med Sci"},{"key":"key-10.4103\/1596-3519.91011-31","first-page":"2421","volume-title":"Effect of blood pressure lowering and anti-hypertensive drug class on progression of hypertensive kidney disease: Results from AASK trial","author":"Wright","year":"2002","journal-title":"JAMA"},{"key":"key-10.4103\/1596-3519.91011-32","first-page":"1206","volume-title":"Seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"key-10.4103\/1596-3519.91011-33","first-page":"S1","volume-title":"Clinical practice guidelines on hypertension and anti-hypertensive agents in chronic kidney disease","author":"NKF-KDOQI","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/1596-3519.91011-34","first-page":"1119","volume-title":"Control of hypertension in adults with chronic kidney disease in the United States","author":"Peratta","year":"2005","journal-title":"Hypertension"},{"key":"key-10.4103\/1596-3519.91011-35","first-page":"2902","volume-title":"Racial differences in the progression from chronic renal insufficiency to end stage renal disease in the united states","author":"Hsu","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/1596-3519.91011-36","first-page":"1501","volume-title":"The prevalence of anaemia in patients with chronic kidney disease","author":"McClellan","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"key-10.4103\/1596-3519.91011-37","doi-asserted-by":"crossref","unstructured":"Levey AS, Beto JA, Coronado BE, Eknoyan G, Foley RN, Kasiske BL, et al. Controlling the epidemic of cardiovascular disease in chronic kidney disease. What Do We Know?. What do we need to learn? Where do we go from here? National kidney foundation task force on cardiovascular disease. Am J Kidney Dis 1998;32:853-906.","DOI":"10.1016\/S0272-6386(98)70145-3"},{"key":"key-10.4103\/1596-3519.91011-38","first-page":"2465","volume-title":"Death, Hospitalization an Economic Association among Incident Haemodialysis Patients with haematocrit Value of 36-39%","author":"Collins","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/1596-3519.91011-39","first-page":"1921","volume-title":"Anaemia in Haemodialysis patients: Variables affecting this outcome predictor","author":"Francois","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/1596-3519.91011-40","first-page":"1642","volume-title":"The impact of haematocrit levels and erythropoietin treatment on mortality and morbidity: The Experience of the Lombardy Dialysis Registry","author":"Locatelli","year":"1998","journal-title":"Nephrol Dial Transpl"},{"key":"key-10.4103\/1596-3519.91011-41","first-page":"610","volume-title":"Heamatocrit level and associated mortality in haemodialysis patients","author":"Colllins","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/1596-3519.91011-42","first-page":"272","volume-title":"Renormalization of high cardiac output and of left ventricular size following long-term recombinant erythropoietin treatment of aneamia in dialyzed ureamic patients","author":"Cannella","year":"1990","journal-title":"Clin Nephrol"},{"key":"key-10.4103\/1596-3519.91011-43","first-page":"217","volume-title":"Electrocardiographic abnormalities and ureamic cardiomyopathy","author":"Stewart","year":"2005","journal-title":"Kidney Int"},{"key":"key-10.4103\/1596-3519.91011-44","first-page":"512","volume-title":"Prevalence and determinants of electrocardiographic left ventricular hypertrophy among a multiethnic population of postmenopausal women (The Women\u2032s Health Initiative)","author":"Oberman","year":"2006","journal-title":"Am J Cardiol"},{"key":"key-10.4103\/1596-3519.91011-45","first-page":"1456","volume-title":"Regression of hypertensive left ventricular hypertrophy by Losartan compared with Atenolol: The Losartan intervention for Endpoint Reduction in Hypertension (LIFE) trial","author":"Devereux","year":"2004","journal-title":"Circulation"},{"key":"key-10.4103\/1596-3519.91011-46","first-page":"41","volume-title":"Meta-analysis of effects of treatment on left ventricular mass in essential hypertension","author":"Klingbell","year":"2003","journal-title":"Am J Med"},{"key":"key-10.4103\/1596-3519.91011-47","first-page":"1491","volume-title":"Effects of Losartan on cardiovascular morbidity and mortality in patients with isolated hypertension and left ventricular hypertrophy: A Losartan Intervention for Endpoint Reduction (LIFE) substudy","author":"Kieldsen","year":"2002","journal-title":"JAMA"},{"key":"key-10.4103\/1596-3519.91011-48","first-page":"249","volume-title":"Serial Change in Echocardiograph Parameters and Cardiac Outcome in ESRD","author":"Foley","year":"1998","journal-title":"J Am Soc Nephrol"}],"container-title":["Annals of African Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:58:27Z","timestamp":1786633107000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1596-3519.91011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"alternative-id":["91011"],"URL":"https:\/\/doi.org\/10.4103\/1596-3519.91011","relation":{},"ISSN":["1596-3519"],"issn-type":[{"value":"1596-3519","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]}}}